Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Subspecialties Microbiology and immunology, Technology and innovation

Getting Ahead of Infectious Disease

Wendy Szymczak, Director, Clinical Microbiology, Montefiore-Einstein Deptartment of Pathology, Bronx, New York, USA.

Culture-based assays are often considered the mainstay of clinical microbiology – but, increasingly, new technologies are offering alternatives that can boost the speed or accuracy of diagnosis. Wendy Szymczak, Director of the Clinical Microbiology Laboratory and Associate Professor of Pathology, Montefiore Health System, Bronx, New York, USA, is exploring these alternatives to bring infectious disease patients faster, more accurate diagnoses and treatment options.

“My colleagues and I began working on a next-generation sequencing (NGS)-based assay to predict antimicrobial resistance to Helicobacter pylori because the organism is very difficult to culture and, even when cultured, grows so slowly that routine phenotypic susceptibility results can take weeks,” says Szymczak. “We were able to show that NGS can accurately predict resistance to clarithromycin and levofloxacin, two antibiotics often used to treat infections.”

But NGS carries challenges of its own – costs, lack of FDA-approved infectious disease assays, the need for bioinformatics expertise, and more. And although Szymczak believes these are surmountable challenges, she and her colleagues are exploring other options.

“We began using MALDI-TOF to identify pathogens directly from blood culture bottles at the end of 2013,” she says. “By using MALDI-TOF as part of the diagnostic workup for two elderly patients with nonspecific clinical presentations, we were able to rapidly identify Listeria monocytogenes from positive blood cultures, which allowed the prompt initiation of pathogen-directed treatment (1).” More recently, the team have adopted multiplex nucleic acid amplification tests (NAAT) to detect pathogens in cerebrospinal fluid (CSF) specimens. “Last month, we had two patients with meningitis caused by L. monocytogenes. The organisms were detected using this NAAT, which provides results in a little over an hour,” says Szymczak. “This is important because blood cultures can take 24 hours or longer before becoming positive, so a NAAT that can be performed directly on CSF can provide a timelier diagnosis.”

To stay at the cutting edge of rapid diagnostics, Szymczak recommends journal clubs, webinars, workshops, and conferences (even virtually). “As these new technologies continue to emerge, we all have a lot to learn, but that’s why I think laboratory medicine is such an exciting field!”

Webinar

Sponsored by Ultivue

Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

Register for our webinar, hosted by The Pathologist and Ultivue and featuring expert speaker Jennifer Giltnane, Principal Pathologist-Scientist at Genentech. By joining this webinar, you will discover whether intratumoral B cells are beneficial in the context of PD-(L)1 blockade or are a general marker of a better prognosis in metastatic NSCLC.

Register today

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. P Nori et al., Clin Microbiol Newsl, 38, 57 (2016).
About the Author
Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register